Stage I Grade 1 Follicular Lymphoma Completed Phase 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0029475 (Stage I Grade 1 Follicular Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00244855Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin LymphomaTreatment
NCT01682044Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone LymphomaTreatment